Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Baxter International Inc (BAX) AI Forecast

Our AI analyzed Baxter International Inc. Create a free account to see the 90-day price prediction.

Free account • 30-day free trial

$BAX Neutral Signal Full forecast available

Baxter International Inc (BAX) Stock Forecast 2025


Baxter International Inc (BAX) AI Stock Price Forecast & Investment Analysis

Baxter International Inc Stock Price Chart and Technical Analysis

Loading chart...

Baxter International Inc (BAX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Baxter International Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 3, 2026, 10:53 a.m. (UTC)

Baxter International Inc Investment Summary

When evaluating whether Baxter International Inc (BAX) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Baxter International Inc (BAX) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. The company employs approximately 32,403 people. With a market capitalization of $10 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Baxter International Inc's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Baxter International Inc along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Baxter International Inc is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Baxter International Inc

Sign Up Free
Corporate Identity

Baxter International Inc (Stock Symbol: BAX) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Baxter International Inc's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Baxter International Inc...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Baxter International Inc...

Unlock Full Company Profile

Get complete details about Baxter International Inc

Sign Up Free
Revenue & Growth Analysis

Baxter International Inc generates annual revenues of $11 billion , demonstrating substantial market presence and operational scale.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Baxter International Inc...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Baxter International Inc...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Baxter International Inc...

Unlock Financial Analysis

Get complete financial metrics for Baxter International Inc

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Baxter International Inc's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Baxter International Inc strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Baxter International Inc competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company demonstrates exceptional operational efficiency through free cash flow generation of $1 billion annually , with year-over-year cash flow growth of -11.2%. This substantial cash generation capability provides significant strategic flexibility for acquisitions, share repurchases, dividend growth, or debt reduction—all while maintaining operational investments necessary to defend market position.

Margin & Pricing Power Analysis

The company maintains a 39.2% gross margin reflecting moderate pricing power typical of many manufacturing, retail, or service businesses. While not exceptionally high, these margins provide adequate room for operating expenses and profit generation. Competitive pressures or cost increases could impact profitability if margins compress.

Operating margin of 10.7% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This healthy operating margin shows balanced investment in growth functions while maintaining reasonable profitability.

Asset Utilization Efficiency

Asset turnover ratio of 0.52x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Current ratio of 2.10 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Baxter International Inc (BAX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Baxter International Inc stock analysis.

Deep dive into Baxter International Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Baxter International Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Baxter International Inc: With a P/E ratio of -94.90, the market sees the stock as potentially undervalued.

P/E Ratio -94.90x
P/B Ratio 1.65x
Market Cap $10.10B
Dividend Yield 0.20%
EPS $-0.31
Book Value/Share $11.95
Revenue/Share $21.92
FCF/Share $2.56
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Baxter International Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Baxter International Inc: An ROE of 12.1% shows good shareholder value creation.

ROE 12.1%
ROA 4.1%
ROIC 6.1%
Gross Margin 39.2%
Operating Margin 10.7%
Net Margin 7.8%
EBT Margin 9.0%
Tax Rate 12.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Baxter International Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Baxter International Inc: A current ratio of 2.10 indicates strong liquidity.

Current Ratio 2.10x
Quick Ratio 1.22x
D/E Ratio 1.90x
Financial Leverage 3.61x
Interest Coverage 5.8x
Working Capital $5.08B
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Baxter International Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Baxter International Inc: Free cash flow of $1341M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $2.05B
Free Cash Flow $1.34B
Capital Spending -$712M
OCF Growth YoY -11.2%
FCF Growth YoY -17.7%
FCF/Sales 9.9%
CapEx/Sales 5.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Baxter International Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Baxter International Inc: An asset turnover of 0.52x suggests room for improvement in asset utilization.

Asset Turnover 0.52x
Receivables Turnover 6.2x
Inventory Turnover 3.6x
Fixed Assets Turnover 2.5x
Days Sales Outstanding 59 days
Days Inventory 101 days
Payables Period 50 days
Cash Conversion Cycle 110 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Baxter International Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Baxter International Inc: With annual revenue of $11244M, Baxter International Inc operates at significant scale.

Income Statement
Total Revenue $11.24B
R&D Expense $590M
SG&A Expense $24M
Cost of Goods Sold $6.65B
Balance Sheet Highlights (% Of Assets)
Total Current Assets 25%
Cash & Short-term Investments 7%
Total Liabilities 72%
Short-term Debt 1%
Accounts Receivable 8%
Inventory 8%
Dividend & Shareholder Information
Dividends Per Share $0.80
Payout Ratio -0.4%
Shares Outstanding 513M
Growth Metrics (YoY)
EPS Growth -3.7%

Latest Baxter International Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Baxter International Inc (BAX) stock price and investment outlook.

📰 We are currently updating our news feed for Baxter International Inc. Check back soon for the latest market analysis and company updates.

Baxter International Inc Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Baxter International Inc against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Adagio Medical Holdings, Inc. ADGM ██% $22M x 2.5x
Aethlon Medical Inc AEMD ██% $2M -0.1x 0.4x
Acutus Medical, Inc. AFIB ██% $0.00M 0.0x -0.4x
Allurion Technologies, Inc. ALUR ██% $9M -0.4x -0.3x
Autonomix Medical, Inc. AMIX ██% $5M x 0.5x
Angiodynamics Inc ANGO ██% $472M -1.4x 2.7x
Anika Therapeutics, Inc. ANIK ██% $158M -4.3x 1.1x
Artivion, Inc. AORT ██% $1.73B 176.7x 3.9x
Apyx Medical Corp APYX ██% $129M -3.5x 22.1x
Accuray Inc ARAY ██% $66M -9.9x 1.2x
Alphatec Holdings, Inc. ATEC ██% $2.02B -7.4x 162.9x
Atricure, Inc. ATRC ██% $1.55B -39.6x 3.2x
Nuo Therapeutics, Inc. AURX ██% $67M x 75.3x
Avita Medical, Inc. AVHHL ██% $22M x x
Baxter International Inc BAX ██% $10.10B -94.9x 1.7x
Beta Bionics, Inc. BBNX ██% $572M x 2.0x
Becton Dickinson & Co BDX ██% $63.96B 36.4x 2.5x
Heartbeam, Inc. BEAT ██% $61M -5.7x 151.2x
Bluejay Diagnostics, Inc. BJDX ██% $1M -0.5x 0.4x
Boston Scientific Corp BSX ██% $111.25B 38.4x 4.6x
Biotricity Inc. BTCY ██% $8M -2.7x 3.4x
Bioventus Inc. BVS ██% $583M 74.6x 3.5x
Brainsway Ltd. BWAY ██% $465M x x
Carlsmed, Inc. CARL ██% $356M x 3.6x
Cerus Corp CERS ██% $486M -13.8x 7.6x
Clearpoint Neuro, Inc. CLPT ██% $279M -23.5x 17.6x
Co-Diagnostics, Inc. CODX ██% $5M -0.7x 0.1x
Cytosorbents Corp CTSO ██% $47M -1.8x 5.2x
Cvrx, Inc. CVRX ██% $216M -5.5x 5.5x
Delcath Systems, Inc. DCTH ██% $310M 114.7x 2.8x
Dih Holding Us, Inc. DHAI ██% $70K x -0.3x
Dariohealth Corp. DRIO ██% $73M 0.6x 1.0x
Alpha Tau Medical Ltd. DRTS ██% $651M x 7.5x
Dexcom Inc DXCM ██% $28.26B 33.8x 10.3x
Dynatronics Corp DYNT ██% $540K -0.2x 0.2x
Ebr Systems, Inc. EBRCZ ██% $253M x 6.5x
Encision Inc ECIA ██% $3M x 1.4x
Embecta Corp. EMBC ██% $608M 4.4x -0.8x
Electromedical Technologies, Inc EMED ██% $370K x x
Femasys Inc FEMY ██% $32M -1.4x 7.0x
Family Office Of America, Inc. FOFA ██% $119M x 147.8x
Glucotrack, Inc. GCTK ██% $2M 0.9x 0.6x
Global Innovative Platforms Inc. GIPL ██% $320K x 2.0x
Glaukos Corp GKOS ██% $6.97B -46.3x 10.6x
Globus Medical Inc GMED ██% $12.68B 23.6x 2.8x
Fractyl Health, Inc. GUTS ██% $77M x 12.1x
Haemonetics Corp HAE ██% $2.99B 17.1x 3.3x
Harvard Apparatus Regenerative Technology, Inc. HRGN ██% $31M x 19.9x
Integra Lifesciences Holdings Corp IART ██% $800M 200.2x 0.8x
Icecure Medical Ltd. ICCM ██% $40M x 13.8x
Seastar Medical Holding Corp ICU ██% $88M -1.1x 7.7x
Icu Medical Inc/De ICUI ██% $3.63B 4957.5x 1.7x
Interpace Biosciences, Inc. IDXG ██% $50M 10.4x 7.3x
Inspira Technologies Oxy B.H.N. Ltd IINN ██% $24M x 5.5x
Inspira Technologies Oxy B.H.N. Ltd IINNW ██% $7M x 1.5x
Intelligent Bio Solutions Inc. INBS ██% $7M -0.3x 0.7x
Infusystem Holdings, Inc INFU ██% $169M 30.5x 3.0x
Inspire Medical Systems, Inc. INSP ██% $1.85B 12.7x 2.4x
Iradimed Corp IRMD ██% $1.32B 62.3x 13.4x
Irhythm Holdings, Inc. IRTC ██% $4.15B -20.2x 27.2x
Invo Fertility, Inc. IVF ██% $6M x 1.1x
Orthopediatrics Corp KIDS ██% $450M -20.7x 1.3x
Kestra Medical Technologies, Ltd. KMTS ██% $1.33B x x
Koru Medical Systems, Inc. KRMD ██% $221M -19.8x 13.4x
Lemaitre Vascular Inc LMAT ██% $2.45B 42.4x 6.2x
Lensar, Inc. LNSR ██% $143M -6.7x 29.4x
Lucid Diagnostics Inc. LUCD ██% $153M -0.6x 5.9x
Pulmonx Corp LUNG ██% $63M -4.3x 1.1x
Lyra Therapeutics, Inc. LYRA ██% $2M -0.1x 1.1x
Microbot Medical Inc. MBOT ██% $162M -1.3x 2.1x
Mountain Crest Acquisition Corp. V MCAG ██% $34M x 1509.8x
Mountain Crest Acquisition Corp. V MCAGU ██% $31M x -9.9x
Spectral Ai, Inc. MDAI ██% $56M -1.3x 38.2x
Medinotec Inc. MDNC ██% $59M 25.1x 10.7x
Mimedx Group, Inc. MDXG ██% $764M 18.7x 3.2x
Monogram Technologies Inc. MGRM ██% $217M -10.7x 25.1x
Meihua International Medical Technologies Co., Ltd. MHUA ██% $151M x 0.9x
3m Co MMM ██% $87.67B 27.0x 18.6x
Merit Medical Systems Inc MMSI ██% $4.59B 35.7x 2.9x
Modular Medical, Inc. MODD ██% $19M -2.1x 3.3x
Nephros Inc NEPH ██% $42M 28.1x 5.0x
Neuroone Medical Technologies Corp NMTC ██% $34M -1.7x 5.3x
Neuropace Inc NPCE ██% $485M -10.4x 26.2x
Inspiremd, Inc. NSPR ██% $78M -4.3x 1.2x
Nu-Med Plus, Inc. NUMD ██% $1M x 6.7x
Novocure Ltd NVCR ██% $1.31B -20.8x 3.9x
Envveno Medical Corp NVNO ██% $7M x 0.2x
Nexgel, Inc. NXGL ██% $9M -6.8x 1.8x
Nyxoah Sa NYXH ██% $192M x x
Orchestra Biomed Holdings, Inc. OBIO ██% $247M -3.4x 2.5x
Odyssey Health, Inc. ODYY ██% $5M x 0.7x
Orthofix Medical Inc. OFIX ██% $539M -5.8x 1.2x
Osr Holdings, Inc. OSRH ██% $10M x 0.1x
Orasure Technologies Inc OSUR ██% $204M 17.1x 0.6x
Pavmed Inc. PAVM ██% $9M 3.0x 0.3x
Pro Dex Inc PDEX ██% $130M 11.4x 3.1x
Penumbra Inc PEN ██% $13.51B 76.0x 9.5x
Petvivo Holdings, Inc. PETV ██% $27M -1.4x 8.0x
Polyrizon Ltd. PLRZ ██% $14M x 0.8x
Pulse Biosciences, Inc. PLSE ██% $1.27B -2.6x 15.8x
Picard Medical, Inc. PMI ██% $80M x 10.0x
Insulet Corp PODD ██% $17.36B 70.3x 11.5x
Procept Biorobotics Corp PRCT ██% $1.28B -45.4x 3.5x
Premier Air Charter Holdings Inc. PREM ██% $2M x 2.6x
Profound Medical Corp. PROF ██% $276M x 8.6x
Plus Therapeutics, Inc. PSTV ██% $54M -0.3x 10.6x
Polypid Ltd. PYPD ██% $77M x 3.8x
Avita Medical, Inc. RCEL ██% $154M -5.0x 34.2x
Vivos Inc RDGL ██% $39M x 17.7x
Resmed Inc RMD ██% $37.33B 25.1x 5.9x
Resmed Inc RSMDF ██% $3.82B 2.7x 0.6x
Retinalgenix Technologies Inc. RTGN ██% $60M x x
Retractable Technologies Inc RVP ██% $20M -0.9x 0.3x
Sight Sciences, Inc. SGHT ██% $271M -3.7x 4.2x
Si-Bone, Inc. SIBN ██% $704M -14.3x 4.1x
Sigyn Therapeutics, Inc. SIGY ██% $80K x 0.2x
Sintx Technologies, Inc. SINT ██% $10M x 2.6x
Beauty Health Co SKIN ██% $191M -1.8x 2.9x
Sonoma Pharmaceuticals, Inc. SNOA ██% $5M -5.6x 1.5x
Sanuwave Health, Inc. SNWV ██% $209M x 199.1x
Solventum Corp SOLV ██% $12.87B 8.3x 2.6x
Sensus Healthcare, Inc. SRTS ██% $68M 31.6x 1.3x
Ss Innovations International, Inc. SSII ██% $922M x 23.2x
Strata Skin Sciences, Inc. SSKN ██% $1M -8.0x 1.0x
Neuronetics, Inc. STIM ██% $92M -1.0x 3.4x
Stimcell Energetics Inc. STME ██% $9M x 1478.6x
Sharps Technology Inc. STSS ██% $48M -2.5x 0.1x
Stevanato Group S.P.A. STVN ██% $4.24B x x
Stryker Corp SYK ██% $148.09B 45.6x 12.6x
Tactile Systems Technology Inc TCMD ██% $657M 34.4x 3.0x
Tela Bio, Inc. TELA ██% $36M -1.8x 22.8x
Teleflex Inc TFX ██% $5.45B 31.0x 1.7x
Trisalus Life Sciences, Inc. TLSI ██% $252M -3.6x 29.8x
Trisalus Life Sciences, Inc. TLSIW ██% $62M x -1.9x
Treace Medical Concepts, Inc. TMCI ██% $118M -7.5x 1.4x
Tandem Diabetes Care Inc TNDM ██% $1.73B -17.1x 11.1x
Tenon Medical, Inc. TNON ██% $10M -0.3x 2.0x
T2 Biosystems, Inc. TTOO ██% $210K 0.0x -0.3x
Ufp Technologies Inc UFPT ██% $1.62B 23.8x 3.8x
Qhslab, Inc. USAQ ██% $9M x 123.2x
Utah Medical Products Inc UTMD ██% $213M 18.3x 1.8x
Venus Concept Inc. VERO ██% $580K 0.0x 0.2x
Catheter Precision, Inc. VTAK ██% $3M x 0.4x
Vivos Therapeutics, Inc. VVOS ██% $16M x 6.3x
Vycor Medical Inc VYCO ██% $4M x 45.1x
West Pharmaceutical Services Inc WST ██% $18.31B 37.1x 5.8x
Beyond Air, Inc. XAIR ██% $10M -0.3x 1.3x
Xtant Medical Holdings, Inc. XTNT ██% $80M 45.6x 1.6x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Baxter International Inc Stock Forecast

How accurate are Baxter International Inc stock predictions?

Our AI model shows a 19% Spearman correlation coefficient for BAX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Baxter International Inc stock price forecasts?

Our analysis considers Baxter International Inc's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Baxter International Inc a good investment in 2025?

Based on our AI analysis, Baxter International Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Baxter International Inc forecasts updated?

Baxter International Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...